Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Suzanne G, Bollmeier"'
Publikováno v:
Journal of the American Pharmacists Association. 61:299-307
Objective Despite evidence-based Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations, outcomes are poor. GOLD uses chronic obstructive pulmonary disease (COPD) assessment test (CAT) scores with exacerbation history to catego
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81afc606ed86432495b99743affa0129
https://doi.org/10.1016/j.japh.2020.12.027
https://doi.org/10.1016/j.japh.2020.12.027
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 62(4)
Understanding types and frequency of medication taking discrepancies could help design pharmacist interventions to improve adherence, outcomes, and prescribing.This study aimed to assess concordance between participants' descriptions of chronic obstr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::335160c0b8030b4c095711ada5f7257a
https://pubmed.ncbi.nlm.nih.gov/35277361
https://pubmed.ncbi.nlm.nih.gov/35277361
Autor:
Kristin Mahan, Emily B. Walsh, Abigail M. Yancey, Rebecca L. Stauffer, Alicia B. Forinash, Erica F. Crannage, Suzanne G. Bollmeier
Publikováno v:
Medical and Clinical Research: Open Access. 2
Objective: To summarize literature assessing the safety and efficacy of budesonide/formoterol, a low dose inhaled corticosteroid (ICS) and long-acting beta agonist (LABA) used as needed for the treatment of adult patients with mild persistent asthma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04d31e766da0447f166a6b8a43a7a223
https://doi.org/10.52106/2766-3213.1025
https://doi.org/10.52106/2766-3213.1025
Publikováno v:
Mo Med
Direct-to-consumer (DTC) telemedicine is increasingly popular and enables patients to obtain medical advice and treatment via electronic media (e.g., computer, telephone, or smartphone) without a prior doctor-patient relationship. Convenience, access
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::04ea54baec551e4fd6bea16b50e2fb25
https://pubmed.ncbi.nlm.nih.gov/32848261
https://pubmed.ncbi.nlm.nih.gov/32848261
Publikováno v:
American Journal of Health-System Pharmacy: AJHP
PurposeChronic obstructive pulmonary disease (COPD) is a significant cause of morbidity and mortality in the United States. Exacerbations— acute worsening of COPD symptoms—can be mild to severe in nature. Increased healthcare resource use is comm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bdf6c7baf0f0c8f07f13e27572ce9c2
https://pubmed.ncbi.nlm.nih.gov/31930287
https://pubmed.ncbi.nlm.nih.gov/31930287
Autor:
Yi-Ting Chou, Richard H. Stanford, Riju Ray, Suzanne G. Bollmeier, Terry L. Seaton, Kristine Reckenberg, Theresa R. Prosser, Beth Hahn
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 59(4)
Objectives Data on symptom burden or medication adherence in patients with chronic obstructive pulmonary disease (COPD) within a community pharmacy setting are limited. This study assessed symptom burden and adherence to respiratory medications in in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10b4e9d3aa4bf45dad2a21ef37baad7c
https://pubmed.ncbi.nlm.nih.gov/31126830
https://pubmed.ncbi.nlm.nih.gov/31126830
Publikováno v:
Pharmacy Today. 19:76-88
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e16ff92e8d6e76e5b8f859dd70b3bf
https://doi.org/10.1016/s1042-0991(15)31072-0
https://doi.org/10.1016/s1042-0991(15)31072-0
Autor:
Shin-Yu Lee, Suzanne G. Bollmeier
Publikováno v:
Annals of Pharmacotherapy. 47:704-713
OBJECTIVE To review clinical data on the use of the long-acting anticholinergic agent tiotropium in patients with asthma. DATA SOURCES A literature search was performed via EMBASE and MEDLINE (1966-November 2012). The search was limited to human data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c02d711ec1a852428ed6fdd5d3e43275
https://doi.org/10.1345/aph.1r641
https://doi.org/10.1345/aph.1r641
Publikováno v:
Patient preference and adherence
Objective Fluticasone furoate (FF), an inhaled corticosteroid (ICS), and vilanterol (VI), a long-acting beta2 receptor agonist (LABA), is a new combination used in an Ellipta® device. This article compares FF–VI to other ICS–LABA combinations av
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0b63b4fd82a6a99a5607f2e5e4e4099
https://pubmed.ncbi.nlm.nih.gov/27257375
https://pubmed.ncbi.nlm.nih.gov/27257375